Silica Nanoparticle as a Lymph Node Targeting Platform for Vaccine Delivery

2017 ◽  
Vol 9 (28) ◽  
pp. 23466-23475 ◽  
Author(s):  
Myunggi An ◽  
Meng Li ◽  
Jingchao Xi ◽  
Haipeng Liu
2021 ◽  
pp. 153537022110107
Author(s):  
Noah Trac ◽  
Eun Ji Chung

The lymph nodes are major sites of cancer metastasis and immune activity, and thus represent important clinical targets. Although not as well-studied compared to subcutaneous administration, intravenous drug delivery is advantageous for lymph node delivery as it is commonly practiced in the clinic and has the potential to deliver therapeutics systemically to all lymph nodes. However, rapid clearance by the mononuclear phagocyte system, tight junctions of the blood vascular endothelium, and the collagenous matrix of the interstitium can limit the efficiency of lymph node drug delivery, which has prompted research into the design of nanoparticle-based drug delivery systems. In this mini review, we describe the physiological and biological barriers to lymph node targeting, how they inform nanoparticle design, and discuss the future outlook of lymph node targeting.


2005 ◽  
Vol 21 (8) ◽  
pp. 705-708 ◽  
Author(s):  
Vladimir Bobek ◽  
Katarina Kolostova ◽  
Daniela Pinterov ◽  
Michael Boubelik ◽  
Ping Jiang ◽  
...  

Author(s):  
Yoshimi Akamo ◽  
Isamu Mizuno ◽  
Toshihisa Yotsuyanagi ◽  
Tatsuo Ichino ◽  
Noritaka Tanimoto ◽  
...  

2020 ◽  
Vol 21 (7) ◽  
pp. 2818-2828 ◽  
Author(s):  
Xiqin Yang ◽  
Tong Yu ◽  
Yingping Zeng ◽  
Keke Lian ◽  
Xueqing Zhou ◽  
...  

2021 ◽  
pp. 101534
Author(s):  
Jihoon Kim ◽  
Paul A. Archer ◽  
Susan N. Thomas

Sign in / Sign up

Export Citation Format

Share Document